Navigation Links
China Kanghui Holdings Announces Shareholder Resolutions Adopted at 2011 Annual General Meeting
Date:9/6/2011

CHANGZHOU, China, Sept. 6, 2011 /PRNewswire-Asia/ -- China Kanghui Holdings (NYSE: KH) ("Kanghui" or the "Company"), a leading domestic developer, manufacturer and marketer of orthopedic implants in China, today announced that all shareholder resolutions proposed at the Company's 2011 annual general meeting held in Hong Kong on September 5, 2011 were duly adopted. Specifically, the shareholders passed resolutions approving:

  1. Re-election of Mr. Yikang Jiang as a Class A director of the Company.
  2. Re-election of Mr. Jun Du as a Class A director of the Company.
  3. Re-election of Ms. Shuchun Gao as a Class A director of the Company.
  4. Appointment of Ernst & Young Hua Ming as independent auditor of the Company for the fiscal year ending December 31, 2011.
  5. Amendment of the 2010 Share Incentive Plan to increase share limit.

Pursuant to the resolutions adopted, Mr. Yikang Jiang, Mr. Jun Du and Ms. Shuchun Gao were re-elected as Class A directors of the Company for a term of three years, Ernst & Young Hua Ming was appointed as independent auditor of the Company for the fiscal year ending December 31, 2011, and the share limit of the Company's the 2010 Share Incentive Plan was increased to 15,793,708 ordinary shares, representing approximately 9.29% of the Company's total outstanding shares on a fully diluted basis as of September 5, 2011.

About China Kanghui HoldingsFounded in 1997, Kanghui is a leading domestic developer, manufacturer and marketer of orthopedic implants in China. The Company offers a wide array of proprietary orthopedic implant products in trauma and spine. It has an extensive network of distributors for its products in China. In addition, Kanghui's products are distributed in 28 countries. Kanghui has strong research and development capabilities, focused on developing new proprietary products, including new product lines, extensions of existing product lines and enhancements of existing products. For more information, please visit www.kanghui.com.Contact:China Kanghui Holdings Investor Relations Department  +1-888-321-2558Asia Bridge Capital LimitedCarene Toh+86-186 1835 6339carene.toh@asiabridgegroup.com
'/>"/>

SOURCE China Kanghui Holdings
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. China Cord Blood Corporation Announces Participation in Upcoming Investor Conferences
2. Top 20 Contract Research Organizations (CRO) - Asia-Pacific, Especially India and China, Positioned to Benefit from Rising Financial and Regulatory Pressures in Western Pharmaceutical Markets
3. China Botanic Pharmaceutical Enters into Research Cooperation with Key Laboratory of Forest Plant Ecology
4. China Nuvo Solar Target Acquisition SurgLine Reports on Marketing Progress
5. China Nepstar Chain Drugstore Announces Share Repurchase Program
6. China Nepstar Chain Drugstore Reports Second Quarter 2011 Financial Results
7. China Nepstar Chain Drugstore Announces Management Change
8. China Medicine Corporation Dismisses Frazer Frost as Auditor
9. VacChina 2011 - Bridging the China Vaccine Industry with the World Class Biotechnologies
10. China Contract Research Organization (CRO) Industry Report, 2010-2011
11. Abbott Expanding Manufacturing Capacity in China to Meet Demands of Fast-Growing Nutrition Market
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/19/2017)... , Jan. 19, 2017 The ... 233.7 billion by 2025, according to a new ... is anticipated to be predominantly driven by high ... into the large-scale production of new and therapeutically ... influx of drugs at an unprecedented rate into ...
(Date:1/19/2017)... Conference Call and Webcast to Follow Vanda ... will release results for the fourth quarter of 2016 on Wednesday, ... ... at 4:30 PM ET on Wednesday, February 15, 2017, during which ... results and other corporate activities. To participate in the conference call, ...
(Date:1/19/2017)... BioTherapeutics Inc. ( Stealth ), a clinical-stage biopharmaceutical company ... additions to its senior leadership team: W. Douglas ... Daniel Geffken as interim Chief Financial Officer. In ... has been promoted to Chief Clinical Development Officer. ... Daniel to our management team, as both will be ...
Breaking Medicine Technology:
(Date:1/20/2017)... ... 2017 , ... Source Vitál Apothecary, a skin and body care company dedicated ... company had a successful visit to the 2017 ECRM Diet, Vitamin & Sports Nutrition ... in the nutritional, sports and health industries a chance to meet in private sessions ...
(Date:1/20/2017)... ... 20, 2017 , ... Bionic Sports Nutrition LLC, an American company devoted to ... a successful January ECRM Trade Show in Hilton Head, SC. , Bionic Sports ... to provide its products to all clients at reasonable prices. At the ECRM trade ...
(Date:1/20/2017)... ... January 20, 2017 , ... ... enhance people’s everyday lives, recently attended the January ECRM Trade Show in Hilton ... is known for its large range of supplements that keep the body functioning ...
(Date:1/20/2017)... , ... January 20, 2017 , ... Michael and Betsy ... Farber Cancer Institute. For Betsy, the clinical trial has been life-saving as she ... not worsened. , Betsy Brauser was diagnosed with ovarian cancer in 2009. She ...
(Date:1/20/2017)... New York, NY (PRWEB) , ... January 20, ... ... drinks – VW+ 001 and its sugar-free alternative VW+ 002. The drinks have ... the body with optimal conditions to perform during your workout. , After a ...
Breaking Medicine News(10 mins):